Analyzing the Impact of Exposure to Antibiotics on Immune Checkpoint Inhibitor Efficacy: Stop at a Methodological Checkpoint

被引：1
|
作者：
Poizeau, Florence [1 ]
Dupuy, Alain [1 ]
机构：
[1] Univ Rennes, CHU Rennes, Irset, Inserm,EHESP,UMR S 1085, Rennes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 32期
关键词：
D O I：
10.1200/JCO.23.00730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5072 / +
页数：2
相关论文
共 50 条
  • [41] Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC
    Serpas, Victoria
    Rogers, Jane Elizabeth
    Xiao, Lianchun
    Mola-Rudd, Kerri
    Dasari, Arvind
    Kee, Bryan K.
    Overman, Michael J.
    Johnson, Benny
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [42] Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
    Bai, Xianguang
    Yi, Ming
    Jiao, Ying
    Chu, Qian
    Wu, Kongming
    ONCOTARGETS AND THERAPY, 2019, 12 : 9527 - 9538
  • [43] Efficacy of dupilumab in patients with immune checkpoint inhibitor-related pruritus
    Shatokhina, E.
    Kruglova, L.
    Polonskaia, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E101 - E102
  • [44] EFFICACY AND SAFETY OF IMMUNE CHECKPOINT INHIBITOR RECHALLENGE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Scheiner, Bernhard
    Pomej, Katharina
    Pressiani, Tiziana
    Cammarota, Antonella
    Fruendt, Thorben W.
    Von Felden, Johann
    Schulze, Kornelius
    Roessler, Daniel
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Deibel, Ansgar
    Siebenhuner, Alexander
    Shmanko, Kateryna
    Radu, Pompilia
    Schwacha, Birgit
    Ebert, Matthias P.
    Teufel, Andreas
    Djanani, Angela
    Hucke, Florian
    Balcar, Lorenz
    Venerito, Marino
    Sinner, Friedrich
    Trauner, Michael H.
    D'Alessio, Antonio
    Pinato, David James
    Peck-Radosavljevic, Markus
    Dufour, Jean-Francois
    Weinmann, Arndt
    Kremer, Andreas E.
    De Toni, Enrico
    Rimassa, Lorenza
    Pinter, Matthias
    HEPATOLOGY, 2022, 76 : S1367 - S1369
  • [45] Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients
    Fox, B.
    de Toro Carmena, M.
    Alvarez Alvarez, R.
    Calles Blanco, A.
    Lopez Lopez, C.
    Perez Ramirez, S.
    Arranz, J. A.
    Martin, M.
    Marquez-Rodas, I
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (04): : 555 - 562
  • [46] Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
    Scheiner, Bernhard
    Roessler, Daniel
    Phen, Samuel
    Lim, Mir
    Pomej, Katharina
    Pressiani, Tiziana
    Cammarota, Antonella
    Fruendt, Thorben W.
    von Felden, Johann
    Schulze, Kornelius
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Deibel, Ansgar
    Siebenhuener, Alexander R.
    Shmanko, Kateryna
    Radu, Pompilia
    Schwacha-Eipper, Birgit
    Ebert, Matthias P.
    Teufel, Andreas
    Djanani, Angela
    Hucke, Florian
    Balcar, Lorenz
    Philipp, Alexander B.
    Fulgenzi, Claudia A. M.
    Pinato, David J.
    Hsiehchen, David
    Venerito, Marino
    Sinner, Friedrich
    Trauner, Michael
    D'Alessio, Antonio
    Fulgenzi, Claudia A. M.
    Pinato, David J.
    Peck-Radosavljevic, Markus
    Dufour, Jean-Francois
    Weinmann, Arndt
    Kremer, Andreas E.
    Singal, Amit G.
    De Toni, Enrico N.
    Rimassa, Lorenza
    Pinter, Matthias
    JHEP REPORTS, 2023, 5 (01)
  • [47] Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
    van Akkooi, Alexander C. J.
    Zijlker, Lisanne P.
    Wouters, Michel W. J. M.
    BIODRUGS, 2022, 36 (03) : 373 - 380
  • [48] Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients
    B. Fox
    M. de Toro Carmena
    R. Álvarez Álvarez
    A. Calles Blanco
    C. López López
    S. Pérez Ramírez
    J. Á. Arranz
    M. Martín
    I. Márquez-Rodas
    Clinical and Translational Oncology, 2020, 22 : 555 - 562
  • [49] Year in review: Translational Research on Immune Checkpoint Inhibitor Efficacy in 2023
    Kumagai, Shogo
    CANCER SCIENCE, 2024, 115 : 714 - 714
  • [50] Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
    Alexander C. J. van Akkooi
    Lisanne P. Zijlker
    Michel W. J. M. Wouters
    BioDrugs, 2022, 36 : 373 - 380
12345